New combo therapy hopes to slow ALS progression
Disease control
Recruiting now
This study tests whether taking N-acetylcysteine (NAC) and EH-301 together with the standard drug riluzole can slow down amyotrophic lateral sclerosis (ALS). About 90 people with early-stage ALS will receive either the active combination or a placebo for 6 months. After that, eve…
Phase: PHASE1, PHASE2 • Sponsor: Biogipuzkoa Health Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC